Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis

S. moon (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Kwak (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea)

Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Session: News on the diagnosis of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 2925
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. moon (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Kwak (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea). Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis. 2925

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020




Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Predictors of Progression in Patients with Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015

Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017




Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary
Source: Guideline 2015
Year: 2015

LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017


Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019